Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting NCT07502677

Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Sclerosis

Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Sclerosis — Recruiting • Respiratory / COPD / Asthma • NCT07502677.

📅 31 Mar 2026 ⏱ 1 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
NCT ID
NCT07502677
Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Start
2026-03-24
ClinicaliQ Trial Snapshot
  • Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Sclerosis — Recruiting • Respiratory / COPD / Asthma • NCT07502677.
  • The specific aim of this study is to try to discover the diagnostic accuracy of SleepImage technology for detecting respiratory failure in patients with MND. Importantly, this research project is not about NIV, it is about what method can most efficiently decide….
  • Sponsor: Royal Brompton & Harefield NHS Foundation Trust.

Verify eligibility, endpoints and current status on the original source registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The specific aim of this study is to try to discover the diagnostic accuracy of SleepImage technology for detecting respiratory failure in patients with MND. Importantly, this research project is not about NIV, it is about what method can most efficiently decide when to start NIV. To do this we'd like to collect data about you and your breathing from the SleepImage device when you come in for your routine overnight sleep study. We will compare this against the data that we would collect anyway.

Eligibility Snapshot
  • : * Patients aged 18 and over with a Neurologist confirmed diagnosis of ALS

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
Your tips on getting a fussy child to eat, and six recipes they’ll love
Respiratory / COPD / Asthma · BBC Health · 21 Jul 2026
Model healthy eating behaviours and involve children in meal planning and food preparation to increase acceptance of nutritious foods like vegetables Offer…
View brief →
Clinical Brief
AI sleep data could provide one-week early warning of flu and COVID-19
Respiratory / COPD / Asthma · UKHSA · 03 Sep 2026
Sleep-tracking apps analysing cough patterns can detect flu and COVID-19 approximately one week before symptom onset, potentially enabling early intervention and isolation…
View brief →
Guideline
Brensocatib for treating non-cystic fibrosis bronchiectasis in people 12 years and over (terminated evaluation)
Respiratory / COPD / Asthma · 25 Aug 2026
Evaluation terminated: Brensocatib for non-CF bronchiectasis is no longer under NICE appraisal—do not initiate new treatment pathways for this indication pending alternative…
View guideline →
Clinical Brief
‘You can talk about your feelings without anybody judging you’
Respiratory / COPD / Asthma · BBC Health · 08 Oct 2026
School-based art interventions may provide a therapeutic outlet for bereaved children to express emotions and process grief in a non-threatening environment Peer…
View brief →
Guideline
XVIVO Perfusion System (ex-situ machine perfusion) for assessing and reconditioning marginal lungs for transplantation: early-use assessment
Respiratory / COPD / Asthma · 21 Oct 2026
XVIVO Perfusion System enables ex-situ assessment of marginal donor lungs before transplantation, allowing objective evaluation of organ viability and function to improve…
View guideline →
Clinical Brief
‘Wildly unfair that my husband and I pay £4k a year for ADHD treatment’
Respiratory / COPD / Asthma · BBC Health · 23 Oct 2026
Northern Ireland lacks a formally commissioned adult ADHD service, unlike the rest of the UK, forcing patients to pursue private treatment at…
View brief →